Recordati (REC.MI) Financial Analysis & Valuation | Quarter Chart
Recordati (REC.MI)
REC.MIPrice: $52.36
Fair Value: 🔒
🔒score
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the cou... more
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the re... more
Description
Shares
| Market Cap | $10.71B | Exchange | MIL |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | IT | CEO | Robert Koremans |
| IPO Date | 1995-03-28 | CAGR | 0.08% |
| Employees | 4,580 | Website | www.recordati.com |
| Div. Yield | 302.86% | Payout Ratio | 0.64% |
| Buy Back Yield | 188.3% | Total Yield | 491.16% |
REC.MI chart loading...
Fundamentals
Technicals
| Enterprise Value | $9.17B | P/E Ratio | 23.44 |
| Forward P/E | 13.18 | PEG Ratio | 0.46 |
| P/S Ratio | 0.04 | P/B Ratio | 0.04 |
| P/CF Ratio | 0.15 | P/FCF Ratio | 0.18 |
| EPS | $2.23 | EPS Growth 1Y | 4.84% |
| EPS Growth 3Y | 21.12% | EPS Growth 5Y | 2.63% |
| Revenue Growth 1Y | 11.51% | Gross Margin | 0.68% |
| Operating Margin | 0.25% | Profit Margin | 0.16% |
| ROE | 0.21% | ROA | 0.08% |
| ROCE | 0.15% | Current Ratio | 1.47 |
| Quick Ratio | 1.01 | Cash Ratio | 0.32 |
| Debt/Equity | 0.04 | Interest Coverage | 6.94 |
| Altman Z Score | 3.27 | Piotroski Score | 6 |